findmyKOL
Clinical trialNCT07158814RecruitingPhase 4Interventional

Safety of RSV Preventive Monoclonal Antibody

SponsorDuke UniversityEnrollment524Adverse Event Following ImmunisationFever
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective, randomized, open-label clinical trial to evaluate the safety of administration of respiratory syncytial virus (RSV) preventive monoclonal antibody and other routine childhood vaccines given simultaneously at Visit 1, as compared to sequential administration of respiratory syncytial virus (RSV) preventive monoclonal antibody and other vaccines at separate visits (Visits 1 and 2).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Kaiser Permanente Northern California

    Oakland, California, United States

    Recruiting
  • Centers for Disease Control and Prevention

    Atlanta, Georgia, United States

    Active, not recruiting
  • Emory University

    Atlanta, Georgia, United States

    Recruiting
  • Columbia University

    New York, New York, United States

    Recruiting
  • Duke University

    Durham, North Carolina, United States

    Recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Respiratory Syncytial Virus Preventive Monoclonal Antibody
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Oct 2025
Primary completion
28 Feb 2027
Completion
30 Apr 2027
Last update posted
16 Mar 2026
Registered enrollment
524
Registry id
NCT07158814
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.